Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

Jim Cramer (CNBC) said the biotech sector may be entering a new wave of mergers and acquisitions as the regulatory environment becomes more favorable for dealmaking. The commentary is bullish but not tied to a specific company, deal size, or earnings/guidance catalyst, so near-term market impact is likely limited.

Analysis

Jim Cramer (CNBC) said the biotech sector may be entering a new wave of mergers and acquisitions as the regulatory environment becomes more favorable for dealmaking. The commentary is bullish but not tied to a specific company, deal size, or earnings/guidance catalyst, so near-term market impact is likely limited.